Copanlisib in Combination with Nivolumab in Subjects with Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Primary Mediastinal Large B-Cell Lymphoma: A Phase II Study

被引：0
|
作者：
Bennani, N. Nora [1 ]
Atherton, Pamela [1 ]
Steinert, Kimberly O. [1 ]
Rimsza, Lisa M. [2 ]
Tun, Aung M. [3 ]
Hoffmann, Marc S. [4 ]
Narkhede, Mayur S. [5 ]
Vaidya, Rakhee [6 ]
Said, Rabih [7 ]
Shapiro, Geoffrey I. [8 ]
Costello, Brian A. [9 ]
Ansell, Stephen M. [10 ]
Nowakowski, Grzegorz S. [10 ]
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Mayo Clin, Dept Lab Med & Pathol, Phoenix, AZ USA
[3] Univ Kansas, Div Hematol Malignancies & Cellular Therapeut, Westwood, KS USA
[4] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA
[5] Univ Alabama Birmingham, Dept Hematol Oncol, Birmingham, AL USA
[6] Wake Forest, Winston Salem, NC USA
[7] NCI, Invest Drug Branch, CTEP, Rockville, MD USA
[8] Dana Farber Canc Inst, Boston, MA 02115 USA
[9] Mayo Clin, Med Oncol, Rochester, MN USA
[10] Mayo Clin, Div Hematol, Rochester, MN USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-190540
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Copanlisib in Combination with Nivolumab in Subjects with Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Primary Mediastinal Large B-Cell Lymphoma: A Phase 2 Study
    Bennani, N. Nora
    Nowakowski, Grzegorz
    Rimsza, Lisa M.
    Adjei, Alex A.
    Doyle, Laurence
    Ansell, Stephen M.
    BLOOD, 2019, 134
  • [2] A Phase I Study of Copanlisib and Venetoclax in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Crombie, Jennifer L.
    Kim, Austin I.
    Bartlett, Nancy L.
    Redd, Robert A.
    Patterson, Victoria
    Carey, Celeste
    Balasubramanian, Sobana
    Odejide, Oreofe O.
    Merryman, Reid W.
    LaCasce, Ann
    Jacobson, Caron A.
    Jacobsen, Eric
    Parry, Erin M.
    Fisher, David C.
    Herrera, Alex F.
    Davids, Matthew S.
    Shipp, Margaret A.
    Armand, Philippe
    Shouse, Geoffrey P.
    BLOOD, 2023, 142
  • [3] Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma
    Armand, Philippe
    Rodig, Scott
    Melnichenko, Vladimir
    Thieblemont, Catherine
    Bouabdallah, Kamal
    Tumyan, Gayane
    Ozcan, Muhit
    Portino, Sergio
    Fogliatto, Laura
    Caballero, Maria D.
    Walewski, Jan
    Gulbas, Zafer
    Ribrag, Vincent
    Christian, Beth
    Perini, Guilherme Fleury
    Salles, Gilles
    Svoboda, Jakub
    Zain, Jasmine
    Patel, Sanjay
    Chen, Pei-Hsuan
    Ligon, Azra H.
    Ouyang, Jing
    Neuberg, Donna
    Redd, Robert
    Chatterjee, Arkendu
    Balakumaran, Arun
    Orlowski, Robert
    Shipp, Margaret
    Zinzani, Pier Luigi
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (34) : 3291 - +
  • [4] Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Friedberg, Jonathan W.
    HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM, 2011, : 498 - 505
  • [5] Salvage chemotherapy and autologous stem cell transplantation are inferior for relapsed or refractory primary mediastinal large B-cell lymphoma compared with diffuse large B-cell lymphoma
    Kuruvilla, John
    Pintilie, Melania
    Tsang, Richard
    Nagy, Tracy
    Keating, Armand
    Crump, Michael
    LEUKEMIA & LYMPHOMA, 2008, 49 (07) : 1329 - 1336
  • [6] Phase II study of single-agent copanlisib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).
    Lenz, Georg
    Hawkes, Eliza
    Verhoef, Gregor
    Haioun, Corinne
    Thye, Lim Soon
    Heo, Dae Seog
    Ardeshna, Kirit
    Chong, Geoffrey
    Christensen, Jacob Haaber
    Shi, Vivian
    Lippert, Susanne
    Niemeyer, Florian
    Piraino, Paolo
    Pena, Carol Elaine
    Buvaylo, Viktoriya
    Childs, Barrett H.
    Gorbatchevsky, Igor
    Salles, Gilles A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [7] The role of pembrolizumab in relapsed/refractory primary mediastinal large B-cell lymphoma
    Tomassetti, Sarah
    Chen, Robert
    Dandapani, Savita
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2019, 10
  • [8] Tafasitamab for refractory/relapsed diffuse large B-cell lymphoma
    Lu, Q.
    Huang, H.
    Tang, S.
    Wang, Y.
    Yang, D-H
    DRUGS OF TODAY, 2021, 57 (09) : 571 - 580
  • [9] Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Dickinson, Michael J.
    Carlo-Stella, Carmelo
    Morschhauser, Franck
    Bachy, Emmanuel
    Corradini, Paolo
    Iacoboni, Gloria
    Khan, Cyrus
    Wrobel, Tomasz
    Offner, Fritz
    Wu, Shang-Ju
    Cartron, Guillaume
    Hertzberg, Mark
    Sureda, Anna
    Perez-Callejo, David
    Lundberg, Linda
    Relf, James
    Dixon, Mark
    Clark, Emma
    Humphrey, Kathryn
    Hutchings, Martin
    Trney, Marek
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (24): : 2220 - 2231
  • [10] Molecular Classification and Treatment of Diffuse Large B-Cell Lymphoma and Primary Mediastinal B-Cell Lymphoma
    Roschewski, Mark
    Phelan, James D.
    Wilson, Wyndham H.
    CANCER JOURNAL, 2020, 26 (03): : 195 - 205
12345